Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

3 AC&R Study Summaries: Lupus Fog, SSc Variance By Ethnicity & Tuberculosis Screening in New DMARD Users

Arthritis Care & Research  |  Issue: August 2024  |  August 7, 2024

Lupus Fog?

By Laura C. Plantinga, PhD, Patricia P. Katz, PhD, S. Sam Lim, MD, MPH, C. Barrett Bowling, MD, MSPH, & Jinoos Yazdany, MD, MPH

Why was this study done? Perceived cognitive impairment (i.e., lupus fog) is common in systemic lupus erythematosus (SLE). However, comprehensive, multidomain assessments of objective cognitive function are rarely performed. Particularly, little is known about SLE and fluid cognition (i.e., the capacity to reason and solve problems in novel situations), which is largely independent of acquired knowledge and acculturation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What were the study methods? Participants from a population-based SLE cohort completed the NIH Toolbox Fluid Cognition Battery—with assessments of episodic memory (i.e., remembering objects, people or events experienced at particular times and places); working memory (i.e., remembering and seeing connections between items or ideas); attention and inhibitory control (i.e., focusing on relevant stimuli in the presence of irrelevant stimuli); processing speed (i.e., taking in and using information); and cognitive flexibility (i.e., shifting thoughts and adapting behavior to new conditions). Age-corrected standard scores (mean score of individuals of the same age from the general U.S. population=100; SD=15) were calculated. Potential impairment was defined as a standard score >1.5 SD below the mean. Descriptive statistics were calculated, and associations of various participant characteristics with potential fluid cognition impairment were assessed with multivariable logistic regression.

What were the key findings? The mean overall fluid cognition score of participants (N=199; mean age, 46; 87% female, 86% Black, 5% Hispanic) was 87.2 (episodic memory, 96.2; working memory, 91.4; attention and inhibitory control, 82.0; processing speed, 93.4; and cognitive flexibility, 94.7). Working status (OR=0.30 [95% CI, 0.14–0.64]) and higher self-reported physical functioning (OR=0.46 [95% CI, 0.28–0.75]) and physical performance (OR=0.72 [95% CI 0.59–0.87]) were associated with lower odds of potential impairment; lower educational attainment was associated with higher odds (OR=3.82 [95% CI, 1.67–8.75]). Self-reported forgetfulness, neuropsychiatric damage and depressive symptoms were not statistically significantly associated with potential impairment.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What were the main conclusions? Scores for fluid cognition were ~1 SD lower than those in the similarly aged general U.S. population. Potential impairment was less frequent among those who were working, had higher physical functioning and performance, and had higher educational attainment.

What are the implications for patients and clinicians? Impairment in fluid cognition may be common in SLE and has implications for self-management. Future work is needed to track fluid cognition among those with SLE to develop and implement interventions that can support fluid cognition and, hopefully, establish treatments that prevent impairment.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch ReviewsResearch RheumSystemic Lupus ErythematosusSystemic Sclerosis Tagged with:Reading RheumSLE Resource CenterTuberculosis

Related Articles

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Progress Continues in Systemic Sclerosis

    March 1, 2010

    Advances in genetics and potential therapies shed new light on the disease

    The Heart-SCC Puzzle

    May 1, 2009

    Identifying and treating cardiac involvement in systemic sclerosis can be a challenge

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences